CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence

Journal of Experimental Medicine

Volumn 203, Issue 11, 2006, Pages 2451-2460

  Yurchenko, Ekaterina ^a   Tritt, Michael ^a   Hay, Valerie ^a   Shevach, Ethan M ^b   Belkaid, Yasmine ^b   Piccirillo, Ciriaco A ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; IN VITRO STUDY; INFECTION RESISTANCE; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SKIN INFECTION;

ANIMALS; CHEMOTAXIS, LEUKOCYTE; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CCR5; T-LYMPHOCYTES, REGULATORY;

EID: 33750530395     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20060956     Document Type: Article

References (48)

1. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
2. Shevach, E.M. 2000. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18:423-449.
3. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531-562.
4. + suppressor T cells. J. Exp. Med. 193:41-46.
5. Klein, L., K. Khazaie, and H. von Boehmer. 2003. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA. 100:8886-8891.
6. + immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin. Immunol. 16:81-88.
7. + regulatory T cells control Leishmania major persistence and immunity. Nature. 420:502-507.
8. + T cells. J. Autoimmun. 16:115-123.
9. + Tregs: limiting collateral damage. J. Clin. Invest. 114:1372-1378.
10. Finlay, B.B., and G. McFadden. 2006. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell. 124:767-782.
11. Belkaid, Y., and B.T. Rouse. 2005. Natural regulatory T cells in infectious disease. Nat. Immunol. 6:353-360.
12. + regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J. Exp. Med. 200:201-210.
13. Hesse, M., C.A. Piccirillo, Y. Belkaid, J. Prufer, M. Mentink-Kane, M. Leusink, A.W. Cheever, E.M. Shevach, and T.A. Wynn. 2004. The pathogenesis of Schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J. Immunol. 172:3157-3166.
14. + regulatory T cells. Nat. Med. 10:29-30.
15. + T cells on Plasmodium berghei NK65 infection in BALB/c mice. Int. J. Parasitol. 33:175-183.
16. + T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J. Immunol. 168:3992-4000.
17. + natural regulatory T cells are specific for microbial antigens. J. Exp. Med. 203:777-788.
18. Charo, I.F., and R.M. Ransohoff. 2006. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354:610-621.
19. Zou, W. 2006. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6:295-307.
20. +) regulatory T cells. J. Exp. Med. 194:847-853.
21. Curiel, T.J., G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J.R. Conejo-Garcia, L. Zhang, M. Burow, et al. 2004. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10:942-949.
22. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169:2461-2465.
23. + T-cell subset. Blood. 105:2877-2886.
24. Bystry, R.S., V. Aluvihare, K.A. Welch, M. Kallikourdis, and A.G. Betz. 2001. B cells and professional APCs recruit regulatory T cells via CCL4. Nat. Immunol. 2:1126-1132.
25. Luster, A.D. 2002. The role of chemokines in linking innate and adaptive immunity. Curr. Opin. Immunol. 14:129-135.
26. + regulatory T cells during acute graft-versus-host disease. Blood. 106:3300-3307.
27. Sato, N., S.K. Ahuja, M. Quinones, V. Kostecki, R.L. Reddick, P.C. Melby, W.A. Kuziel, and S.S. Ahuja. 2000. CC chemokine receptor (CCR)2 is required for Langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation. J. Exp. Med. 192:205-218.
28. Sato, N., W.A. Kuziel, P.C. Melby, R.L. Reddick, V. Kostecki, W. Zhao, N. Maeda, S.K. Ahuja, and S.S. Ahuja. 1999. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR)5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice. J. Immunol. 163:5519-5525.
29. + regulatory T cells is not essential for suppression of intestinal inflammation. Eur. J. Immunol. 35:2886-2895.
30. + regulatory T cells. Trends Immunol. 25:374-380.
31. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 199:1479-1489.
32. + regulatory T cells. J. Immunol. 170:3939-3943.
33. + regulatory T cells control autoimmunity? Curr. Opin. Immunol. 17:638-642.
34. + regulatory T cells in Leishmania infection. Expert Opin. Biol. Ther. 3:875-885.
35. + T cells control virus-specific memory T cells in chimpanzees recovered from Hepatitis C. Blood. 107:4424-4432.
36. + regulatory T cells in viral infections. Vet. Immunol. Immunopathol. 108:219-225.
37. + regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity. 23:287-296.
38. D'Ambrosio, D., F. Sinigaglia, and L. Adorini. 2003. Special attractions for suppressor T cells. Trends Immunol. 24:122-126.
39. Putheti, P., M. Morris, L. Stawiarz, N. Teleshova, P. Kivisakk, M. Pashenkov, M. Kouwenhoven, M.K. Wiberg, L. Bronge, Y.M. Huang, et al. 2003. Multiple sclerosis: a study of chemokine receptors and regulatory T cells in relation to MRI variables. Eur. J. Neurol. 10:529-535.
40. Belkaid, Y., K.F. Hoffmann, S. Mendez, S. Kamhawi, M.C. Udey, T.A. Wynn, and D.L. Sacks. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194:1497-1506.
41. Lemos de Souza, V., J. Ascencao Souza, T.M. Correia Silva, P. Sampaio Tavares Veras, and L.A. Rodrigues de-Freitas. 2000. Different Leishmania species determine distinct profiles of immune and histopathological responses in CBA mice. Microbes Infect. 2:1807-1815.
42. Kane, M.M., and D.M. Mosser. 2001. The role of IL-10 in promoting disease progression in Leishmaniasis. J. Immunol. 166:1141-1147.
43. Molon, B., G. Gri, M. Bettella, C. Gomez-Mouton, A. Lanzavecchia, C. Martinez-A, S. Manes, and A. Viola. 2005. T cell costimulation by chemokine receptors. Nat. Immunol. 6:465-471.
44. Luther, S.A., and J.G. Cyster. 2001. Chemokines as regulators of T cell differentiation. Nat. Immunol. 2:102-107.
45. Teixeira, M.J., J.D. Fernandes, C.R. Teixeira, B.B. Andrade, M.L. Pompeu, J. Santana da Silva, C.I. Brodskyn, M. Barral-Netto, and A. Barral. 2005. Distinct Leishmania braziliensis isolates induce different paces of chemokine expression patterns. Infect. Immun. 73:1191-1195.
46. Antoniazi, S., H.P. Price, P. Kropf, M.A. Freudenberg, C. Galanos, D.F. Smith, and I. Muller. 2004. Chemokine gene expression in toll-like receptor-competent and -deficient mice infected with Leishmania major. Infect. Immun. 72:5168-5174.
47. Ji, J., J. Sun, and L. Soong. 2003. Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect. Immun. 71:4278-4288.
48. Belkaid, Y., S. Mendez, R. Lira, N. Kadambi, G. Milon, and D. Sacks. 2000. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J. Immunol. 165:969-977.